Sidley Austin is representing Nektar Therapeutics in the transaction, and Goodwin Procter is representing Ampersand Capital Partners. Ampersand has agreed to acquire Nektar’s commercial-scale manufacturing facility...
Ampersand’s Acquisition of a Nektar’s Manufacturing Facility and Reagent Supply Business
JMI Equity’s $85 Million Investment in ServiceTrade
Goodwin Procter advised JMI Equity on the deal. JMI Equity announced its $85 million growth investment in ServiceTrade. With the additional capital, ServiceTrade will increase the pace...